Literature DB >> 28317525

Chemical-Induced Vitiligo.

John E Harris1.   

Abstract

Chemical-induced depigmentation of the skin has been recognized for more than 75 years, first as an occupational hazard but then extending to those using household commercial products as common as hair dyes. Since their discovery, these chemicals have been used therapeutically in patients with severe vitiligo to depigment their remaining skin and improve their appearance. Because chemical-induced depigmentation is clinically and histologically indistinguishable from nonchemically induced vitiligo, and because these chemicals appear to induce melanocyte autoimmunity, this phenomenon should be known as "chemical-induced vitiligo," rather than less accurate terms that have been previously used.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoimmunity; Cellular stress; Chemical; Leukoderma; Monobenzone; Phenol; Rhododendrol; Vitiligo

Mesh:

Substances:

Year:  2017        PMID: 28317525      PMCID: PMC5362111          DOI: 10.1016/j.det.2016.11.006

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  72 in total

1.  Leukomelanoderma subsequent to the application of monobenzyl ether of hydroquinone; a vitiligoid reaction observed in Colombia and Venezuela.

Authors:  O CANIZARES; F URIBE JARAMILLO; F KERDEL VEGAS
Journal:  AMA Arch Derm       Date:  1958-02

2.  4-(4-hydroroxyphenyl)-2-butanol (rhododendrol) activates the autophagy-lysosome pathway in melanocytes: insights into the mechanisms of rhododendrol-induced leukoderma.

Authors:  Lingli Yang; Fei Yang; Mari Wataya-Kaneda; Atsuhi Tanemura; Daisuke Tsuruta; Ichiro Katayama
Journal:  J Dermatol Sci       Date:  2015-01-28       Impact factor: 4.563

3.  Chemical leukoderma from hair dye containing para-phenylenediamine.

Authors:  Terry T Farsani; Hrak Ray Jalian; Lorraine Clarke Young
Journal:  Dermatitis       Date:  2012 Jul-Aug       Impact factor: 4.845

4.  Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser.

Authors:  M D Njoo; R M Vodegel; W Westerhof
Journal:  J Am Acad Dermatol       Date:  2000-05       Impact factor: 11.527

5.  Occupational vitiligo.

Authors:  M Das; A Tandon
Journal:  Contact Dermatitis       Date:  1988-03       Impact factor: 6.600

Review 6.  Contact leukoderma secondary to para-phenylenediamine.

Authors:  R Brancaccio; D E Cohen
Journal:  Contact Dermatitis       Date:  1995-05       Impact factor: 6.600

7.  Contact leukoderma of the scalp or an unusual variant of vitiligo?

Authors:  S Verma; B Kumar
Journal:  J Dermatol       Date:  2001-10       Impact factor: 4.005

8.  [The etiology and pathogenesis of occupational vitiligo].

Authors:  G P Babanov; N N Chumakov
Journal:  Vestn Dermatol Venerol       Date:  1966-11

9.  Occupational depigmentation due to 4-tertiarybutyl catechol (TBC).

Authors:  G A Gellin; P A Possick; I H Davis
Journal:  J Occup Med       Date:  1970-10

10.  Contact depigmentation from free para-tertiary-butylphenol in bindi adhesive.

Authors:  A K Bajaj; S C Gupta; A K Chatterjee
Journal:  Contact Dermatitis       Date:  1990-02       Impact factor: 6.600

View more
  18 in total

1.  Face and Neck Pigmentary Alterations in Hair Dye Users: A Cross-sectional Study from South India.

Authors:  Valeti Meghana; Hima Gopinath; Kaliaperumal Karthikeyan; Vinayagamoorthy Venugopal
Journal:  Indian Dermatol Online J       Date:  2020-09-19

Review 2.  Biochemical Mechanism of Rhododendrol-Induced Leukoderma.

Authors:  Shosuke Ito; Kazumasa Wakamatsu
Journal:  Int J Mol Sci       Date:  2018-02-12       Impact factor: 5.923

3.  Carvedilol, an Adrenergic Blocker, Suppresses Melanin Synthesis by Inhibiting the cAMP/CREB Signaling Pathway in Human Melanocytes and Ex Vivo Human Skin Culture.

Authors:  Myoung Eun Choi; Hanju Yoo; Ha-Ri Lee; Ik Joon Moon; Woo Jin Lee; Youngsup Song; Sung Eun Chang
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

Review 4.  Chemical Vitiligo: A Subset of Vitiligo.

Authors:  Sanjay Ghosh
Journal:  Indian J Dermatol       Date:  2020 Nov-Dec       Impact factor: 1.494

5.  A Nationwide, Multicentric Case-Control Study on Vitiligo (MEDEC-V) to Elicit the Magnitude and Correlates.

Authors:  Nilendu Sarma; Sayantani Chakraborty; Shital Poojary; B M Shashi Kumar; Lalit Kumar Gupta; Leelavathy Budamakuntla; Leishiwon Kumrah; Suchibrata Das; Ajay Govindrao Ovhal; Nirmal Kumar Mandal; Shuvankar Mukherjee; T V Anoop; Binod Kumar Thakur; L Eswari; Joan Felicita Samson; Krina Bharat Patel; Rajesh Rajagopalan; Sanjeev Gupta; Tejinder Kaur
Journal:  Indian J Dermatol       Date:  2020 Nov-Dec       Impact factor: 1.494

Review 6.  Translational Research in Vitiligo.

Authors:  Erica L Katz; John E Harris
Journal:  Front Immunol       Date:  2021-03-02       Impact factor: 7.561

Review 7.  Clinical Features, Immunopathogenesis, and Therapeutic Strategies in Vitiligo.

Authors:  Yinghan Wang; Shuli Li; Chunying Li
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-20       Impact factor: 8.667

8.  Frontal fibrosing alopecia preceding the development of vitiligo: A case report.

Authors:  Brianna De Souza; Laura Burns; Maryanne Makredes Senna
Journal:  JAAD Case Rep       Date:  2020-01-30

Review 9.  A Concise Review on the Role of Endoplasmic Reticulum Stress in the Development of Autoimmunity in Vitiligo Pathogenesis.

Authors:  Shahnawaz D Jadeja; Jay M Mayatra; Jayvadan Vaishnav; Nirali Shukla; Rasheedunnisa Begum
Journal:  Front Immunol       Date:  2021-02-04       Impact factor: 7.561

10.  Contact leukoderma following irritant contact dermatitis to an isopropanol-based hand rub: A consequence of rigorous hand hygiene.

Authors:  Surabhi Sinha; Kabir Sardana
Journal:  Contact Dermatitis       Date:  2020-12-01       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.